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ABSTRACT 
Guillain-Barre Syndrome is serious health problem, that occurs when the body`s defence system 
mistakenly attacks parts of the nervous system. In about 50% of people with these syndrome 
symptoms begin about 5 days to 3 weeks after a mild infection symptoms include weakness and pin 
and needle sensation or loss of sensation. It is form of polyneuropathy that cause one episode of 
increasing muscle weakness. Weakness is more prominent than abnormal sensation reflex. Usually 
weakness begins both legs and moves up the body. In GBS, the body`s immune system attacks the 
myelin sheath which surround the axon of many nerves and enable nerve impulses to travel 
quickly. It may lead to life threatening complication in particular if respiratory muscles are affected 
or if the autonomic nervous system is involved. Worldwide, the annual incidence is about 0.6- 4.0 
occurrences per 1,00,000 people. Electromyography and nerve conduction studies can help confirm 
the diagnosis. Plasmapheresis or immunoglobulin given intravenously may speed recovery. GBS as 
such is not correlated with any disease which is described in Ayurveda but pathology of GBS is Vata 
dominating disorder along with association of Pitta and Kapha dosha. As a precipitating factor 
produced functions of GI biofire plays an important role by producing Ama like reactive species in 
genesis of this disease. So at the management of GBS through Ayurveda anti-Vata and anti-Ama 
measures kept in mind while prescribing the drug. 
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INTRODUCTION 
 GBS syndrome is the commonest acute 
polyneuropathy which is presumed to autoimmune 
in nature.[1] The syndrome is named after the French 
physician Georges Guillian and Jean Alexandre Barre, 
who described it in 1916.[2] It is heterogeneous group 
of immune mediate condition with an incidence of 1-
2/100000/year.[3] Possibility of any person acquiring 
GBS in lifetime is 1: 1000. The term GBS is often 
considered to be synonymous of AIPD but with 
increasing recognition over the past few decades of 
variants the number of disease that fall under the 
rubric GBS has grown to include axonal variants and 
more restricted variants, such as miller- fisher 
syndrome. In India peak incidence is between June-
July and September – October. In India it is more 
common in younger age. Generally there is no sex 
preponderance and can occur at any age.[4] In 
Western countries adults are frequently affected then 
children. [5] GBS occurs when the body’s defence 
system mistakenly attack parts of nervous system. An 
autoimmune reaction may damage the myelin sheath 
around nerve. This lead to nerve inflammation 
results in conduction block, severe form show 
secondary axonal degeneration and cause muscle 
weakness or paralysis and other symptoms.[6] The 
hallmark is an acute paralysis evolving over days or 
weeks with loss of tendon reflexes.[3] Ascending 
paralysis weakness at beginning in the feet hands and 
migrating towards the trunk is most typical 
symptoms. While some subtypes causes changes in 
sensation or pain as well dysfunction of the 
autonomic nervous system. The disease is usually 
triggered by an infection. It is most common cause of 
non trauma related paralysis. It may lead to life 
threatening complication, in particular if the 
respiratory muscles are affected or if the autonomic 
nervous system is involved.[2] In Ayurveda GBS is not 
correlated with any diseases. But seeing the 
pathophysiology of GBS we can say that it is Vata 
dominating disorder along with association of Pitta 
and Kapha dosha. As precipitating factor reduced 
functions of GI biofire play an important role by 
producing Ama like reactive species in genesis of the 
disease. Ama itself have immense role along with it 
also vitiate the other Doshas too. Therefore at the 
time of management of GBS through Ayurveda anti 
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Vata and anti Ama measures kept mind while 
prescribing the drugs.[7] 
Etiology[8] 
Many infections can trigger GBS. Commonly 
implicated infections are Campylobacter jejuni 
infection, cytomegalovirus, Epstein-Barr virus, and 
human immunodeficiency virus (HIV). Other 
triggering events are immunization (influenza, 
meningococcal, etc), Systemic lupus erythemetosus, 
Hodgkin disease, Mycoplasma pneumonia, surgery, 
trauma and bone marrow transplantation. 
Pathogenesis 
Guillain-Barre syndrome results from an 
immune response to a preceding infection that cross- 
reacts with peripheral nerve components because of 
molecular mimicry. The immune response can be 
directed towards the myelin or the axon of peripheral 
nerve, resulting in demyelinating and axonal forms of 
GBS. Nerve damage is due to activated T cells and 
circulating antibodies such as antimyelin 
antibodies.[8] GBS damages parts of nerves that cause 
tingling, muscle weakness and paralysis. Damage to 
other parts of the nerve, can cause, the nerves to stop 
working altogether.[9] 
Pathophysiology[10] 
In the demyelinating forms of GBS, the basis 
for flaccid paralysis and sensory disturbance is 
conduction block. This finding, demonstrable electro 
physiologically, implies that the axonal connection 
remain intact. Hence, recovery can take place rapidly 
as remyelination occurs. In severe cases of 
demyelinating GBS, secondary axonal degeneration 
usually occurs; its extent can be estimated electro 
physiologically. More secondary axonal degeneration 
correlates with a slower rate of recovery and a 
greater degree of residual disability. When a primary 
axonal pattern is encountered electro physiologically, 
the implication is that axons have degenerated and 
become disconnected from their targets, specifically 
the neuromuscular junction, and must therefore 
regenerate for recovery to take place. In motor 
axonal cases in which recovery is rapid, the lesion is 
thought to be localized to preterminal motor 
branches, allowing regeneration and reinnervation to 
take place quickly. 
Subtypes of Guillain- Barre syndrome[11] 
Acute inflammatory demyelinating polyneuropathy 
(AIDP): It is the most common form of GBS, and the 
term is often used synonymously with GBS. It is 
caused by an autoimmune response directed against 
Schwann cell membranes.  
Miller fisher syndrome: Demyelinating type. 
Accounting for about 5% of GBS cases, it manifests as 
a descending paralysis, proceeding in the reverse 
order of the more common form of GBS. It usually 
affects the eye muscles first and presents with the 
triad of opthalmoplegia, ataxia, and areflexia. The 
ataxia predominantly affects the gait and trunk with 
the limbs relatively spared. Anti-GQ1b antibodies are 
present in 90% of cases. 
Acute motor axonal neuropathy (AMAN): It also 
known as Chinese paralytic syndrome. It is probably 
due to an auto- immune response directed against 
the axoplasm of peripheral nerves. The disease may 
be seasonal and recovery can be rapid. Anti –GD1 A 
antibodies are present. 
Acute motor sensory axonal neuropathy AMSAN): 
It is similar to AMAN, but also affects sensory nerves 
with severe axonal damage. Like AMAN, It is probably 
due to an autoimmune response directed against the 
axoplasm of peripheral nerves. Recovery is slow and 
often incomplete. 
Acute panautonomic neuropathy: it is the rarest 
variants of GBS, sometimes accompanied by 
encephalopathy. It is associated with a high mortality 
rate, owing to cardiovascular involvement, and 
associated with dysrrhythmias. Frequently occurring 
symptoms include impaired sweating, lack of tear 
formation, photophobia, Dryness of nasal & oral 
mucosa, itching & peeling of skin, nausea, dysphagia, 
and constipation unrelieved by laxatives or 
alternating with diarrhoea. 
Bickerstaff`s brainstem encephalitis (BBE): It is 
further variant of GB syndrome, which is 
characterized by acute onset of opthalmoplegia, 
Atexia, disturbance in consciousness, hyperreflexia or 
babinsbki`s sign. The course of the disease can be 
monophasic or remitting-relapsing. 
Clinical features 
The cardinal features of GBS are progressive 
symmetric muscle weakness and absent or depressed 
deep tendon reflexes.[8] GBS manifests as rapidly 
evolving areflexic motor paralysis with or without 
sensory disturbance. The usual pattern is an 
ascending paralysis that may be first noticed as 
rubbery legs. Weakness typically evolves over hours 
to a few days and is frequently accompanied by 
tingling dysesthesias in the extremities[5]. Weakness 
can vary from mild weakness of legs to complete 
paralysis of all extremity, facial, respiratory, and 
bulbar muscles. Weakness usually starts in the lower 
limbs, and then ascends up to involve trunk and 
upper limbs (ascending paralysis). However, in some 
Patients weakness can begin in the arm or facial 
muscles and then descend down to involve trunk and 
lower limbs (descending paralysis).[8] The legs are 
usually more affected than the arms, and xs is present 
in 50% of affected individuals. The lower cranial 
nerves are also frequently involved, causing bulbar 
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weakness and difficulty with handling secretions and 
maintaining an airway.[5] Because the facial and 
swallowing muscle become weak, a few people need 
to be fed intravenously or through a tube placed 
directory through the abdominal wall into the 
stomach.[12] Severe respiratory muscle weakness may 
lead to respiratory failure and requires ventilator 
support.[8] Most patients require hospitalization, and 
almost 30% require ventilator assistance at some 
time during the illness. Fever and constitutional 
symptoms are absent at the onset, and, if present, 
cast doubt on the diagnosis. Deep tendon reflexes 
usually disappear within the first few days of onset. 
Cutaneous sensory deficits, e.g., loss of pain and 
temperature sensation, are usually relatively mild, 
but functions sub served by large sensory fibers such 
as deep tendon reflexes and proprioception, are more 
severely affected. Bladder dysfunction may occur in 
severe cases but usually transient. If bladder 
dysfunction is a prominent feature and comes early 
in the course, possibilities other than GBS should be 
considered, particularly spinal cord disease. In severe 
cases of GBS requiring critical care management, 
autonomic involvement is common. Usual features 
are loss of vasomotor control with wide fluctuation in 
blood pressure, postural hypotension, and cardiac 
dysrhythmias.  
Pain is another common feature of GBS; several types 
are encountered. Most common is deep aching pain 
in weakened muscles, which patients liken to having 
over exercised the previous day. Other pains in GBS 
include back pain involving the entire spine and 
sometimes dysthetic pain in the extremities as a 
manifestation of sensory nerve fiber involvement. 
These pains are self limited and should be treated 
with standard analgesics. GBS usually progress over a 
period of about two weeks and recovery starts after 
about a month.[5] 
Course: Muscle weakness gradually progresses over 
1-3 weeks and then plateaus over next several days 
to weeks before gradual recovery. On recovery, 
nearly 15% patients do not have any deficit while 
minor deficits and major deficits occur in nearly 70% 
and 5-10% cases, respectively.[1] 
On examination:[13] 
Onset: Acute or subacute with fever, backache and 
pain in the limbs. 
Sensory: Pain and paraesthesia over the affected 
limbs with or without sensory loss. Muscle 
tenderness may be present. 
Motor: weakness of all the four limbs simultaneously 
or first in the lower limbs and then spreading to the 
upper limbs. Proximal weakness more than distal. 
Cranial nerves: Unilateral or bilateral facial palsy, 
dysphagia (from pharyngeal palsy) and external 
ophthalmoplegia. 
CSF: Xanthochromia with cytoalbuminic dissociation.  
Investigation 
GBS is difficult to diagnose at first. This is 
because the symptoms are very similar to those of 
other neurological disorders or conduction that 
affects the nervous system such as botulism, Heavy 
metal poisoning, or meningitis. A careful medical 
history along with the following tests is useful to 
confirm the diagnosis. 
Nerve conduction studies (NCS) and 
electromyography (EMG) are used to confirm the 
diagnosis and also to know the type of GBS. 
Abnormalities in NCS that are consistent with 
demyelination are delayed distal latencies, slowed 
nerve conduction velocities, conduction block, etc. In 
case of axonal damage, needle EMG will show 
decreased recruitment and rapid firing motor units in 
weak muscles. 
CSF analysis: CSF may be normal in the first 10 days. 
Protein is elevated with normal WBC count. This is 
known as albuminocytologic dissociation, and is 
present in most patients one week after the onset of 
symptoms. However, cell count may be increased in 
patients with HIV infection.  
Antibodies: Against nerve component can be 
detected in the blood of GBS patients. However, 
antibody testing is not routinely used. Antibodies to 
the ganglioside GM1 are found in about 25%, usually 
the motor axonal form.[8] 
Reflexes, especially the knee jerk are usually 
diminished.[12] 
Other causes of an acute neuromuscular paralysis 
should be excluded (e.g. poliomyelitis, botulism, 
diphtheria, spinal cord syndrome or myasthenia), via 
the history and examination rather than 
investigation.[3] 
Treatment 
Plasmaphresis remove the circulating 
antibodies and help in fast recovery. 4 sitting of 
plasmaphresis are recommended. 
Intravenous immune globulin (IVIG) probably 
acts by neutralizing circulating antibodies and 
immunomodulation. IVIG is given in a dose of 0.4 
g/kg daily for 6 days.  
Both plasmapheresis and IV immunoglobins 
have equal efficacy and combining both of them is not 
better than anyone given alone. 
Steroids: IV methyl prednesolone (1 gm IV infusion 
daily for 5 days) used to be popular earlier, but 
studies have shown that it does not provide any 
benefit in GBS. 
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Supportive therapy: bowel and bladder care, 
adequate nutrition, monitoring for respiratory failure 
and providing ventilator support if required, cardiac 
monitoring, and physiotherapy are all important.[14] 
Physical therapy helps to keep joints and muscles 
healthy. 
Blood thinners may be used to prevent blood clots. 
Proper body positioning or a feeding tube may be 
used to prevent choking during feeding if the muscles 
used for swallowing are weak.[7] 
In Ayurveda aspect 
Guillain Barre Syndrome commonly occurs 
post viral or any other infections. Seeing the 
pathophysiology of GBS we can say that it is Vata 
dominating disorder with association of Pitta and 
Kapha dosha. Due to Kapha Avaranum, Vitiated Vata 
and Pitta accumulated in the Majja Dhatu and cause 
Dhatu Kshaya and Oja Kshya. Here is Mandagni play 
an important role as a precipitating factor.[15] 
Line of treatment:[16] 
Principle applicable as for Jvara Chikitsa 
Avarana treatment and Dhatu Paka are needed. 
Sannipata Jvara Chikitsa, Kapha Jvara Chikitsa  
Ayurvedic management[17] 
Medicines to treat nerve damage: Drugs like Yograj 
Guggulu, Kaisore Guggulu, Trayodasanga Guggulu, 
Panchtiktagrita Guggulu, Mahavatavidhvansani Rasa, 
Vata Gajankusha Rasa, Lashunadi Vati, Chitrakadi 
Vati, Hinguvadi Vati, Kupiluhinguvadi Vati, 
Kapikacchu Churna, Ashvagandha Churna and 
Dashamularista are usually treat nerve damage. 
Herbal medicine: Yastimadhu, Manjistha, 
Mandukaparni, Nirgundi, and Dashamula are also 
very useful in this condition. 
Medicines which act on the Majja dhatu of the 
body are also very effective in treating this condition 
such as Punarnava mandura, Tapyadi lauha, Guduchi, 
Amalaki and Mustaka. 
In addition localized Panchakarma therapy 
can also be used for the management of GBS. In acute 
phase, lasting for the first 3 to 6 weeks, only 
medicated steam fomentation is advised. After this 
period, medicated oils are used to massage the body, 
followed by medicated steam fomentation. Medicines 
used for these procedures are Mahanarayana oil, 
Mahamasa oil, Mahasaindhava oil, Dashamula Kvath 
and Nirgundi Kvath. 
Ashvagandha, Yastimadhu, Tulasi, and 
Bhringaraja are used to correct immune dysfunction 
in the body. Assurance therapy is also advised to 
counteract the mental stressors. 
Yogasana: Pranayama and Suryanamaskara are 
useful. 
CONCLUSION 
GBS is an acute, frequently severe, and 
fulminant polyradiculoneuropathy that is 
autoimmune in nature.[5] An autoimmune reaction 
may damage the myelin sheath around the nerve. 
This damage is called demyelination. Damage parts of 
nerves cause tingling, muscle weakness, and 
paralysis. It causes nerve signals to move slowly. 
Damage to other parts of the nerve, can cause, the 
nerves to stop working altogether. In Ayurvedic 
aspect GBS occurs due to Kapha avarana, vitiated 
Vata and Pitta accumulated in the Majja dhatu and 
cause Dhatu kshya, Oja kshya. So line of treatment of 
GBS is Jvara chikitsa, Avarana treatment, & Dhatu 
paka. Thus medicines that work on the nerve 
damage, immune dysfunction, and Majja dhatu are 
useful in the treatment of GBS. 
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